The Drug Control Authority (DCA) has extended the approval of Sinovac’s Covid-19 vaccine to children aged 5 to 11 years, making it the second vaccine approved in Malaysia for this age group.

In addition, it has approved Pfizer’s antiviral pill Paxlovid for the treatment of certain Covid-19 patients who are at high risk of developing severe symptoms later on.